These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 73693)

  • 1. A new approach to the management of familial hypercholesterolaemia: Removal of plasma-cholesterol based on the principle of affinity chromatography.
    Lupien PJ; Moorjani S; Awad J
    Lancet; 1976 Jun; 1(7972):1261-5. PubMed ID: 73693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extracorporeal removal of cholesterol in familial hypercholesterolemia].
    Lupien PJ; Brun LD; Moorjani S; Gagné C; Awad J
    Union Med Can; 1979 May; 108(5):558-65. PubMed ID: 229607
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of intravenous hyperalimentation of plasma-lipoproteins in severe familial hypercholesterolaemia.
    Torsvik H; Feldman HA; Fischer JE; Lees RS
    Lancet; 1975 Mar; 1(7907):601-4. PubMed ID: 47947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange in the management of homozygous familial hypercholesterolaemia.
    Thompson GR; Lowenthal R; Myant NB
    Lancet; 1975 May; 1(7918):1208-11. PubMed ID: 48833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intessive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia.
    Apstein CS; Zilversmit DB; Lees RS; George PK
    Atherosclerosis; 1978 Oct; 31(2):105-15. PubMed ID: 215170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.
    Stoffel W; Borberg H; Greve V
    Lancet; 1981 Nov; 2(8254):1005-7. PubMed ID: 6118475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of cholesterol from blood by affinity binding to heparin-agarose: evaluation on treatment in homozygous familial hypercholesterolemia.
    Lupien PJ; Moorjani S; Lou M; Brun D; Gagné C
    Pediatr Res; 1980 Feb; 14(2):113-7. PubMed ID: 7360525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal removal of plasma lipoproteins by affinity binding to heparin-agarose.
    Moorjani S; Lupien PJ; Awad J
    Clin Chim Acta; 1977 May; 77(1):21-30. PubMed ID: 194736
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum phospholipids in children with familial hypercholesterolaemia.
    Shoksey S; Fosbrooke A
    Clin Chim Acta; 1973 Aug; 47(1):93-6. PubMed ID: 4355897
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholesterol removal by haemoperfusion of whole blood in vivo.
    Tabak A; Lotan N; Sideman S; Tzipiniuk A; Bleiberg B; Brook G
    Life Support Syst; 1986; 4(4):355-65. PubMed ID: 3561033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous flow plasma exchange in the treatment of homozygous familial hypercholesterolemia.
    Berger GM; Miller JL; Bonnici F; Joffe HS; Dubovsky DW
    Am J Med; 1978 Aug; 65(2):243-51. PubMed ID: 210664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol at birth and age 1: comparison of normal and hypercholesterolemic neonates.
    Tsang RC; Fallat RW; Glueck CJ
    Pediatrics; 1974 Apr; 53(4):458-70. PubMed ID: 4362901
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-sorbent for low density lipoproteins removal in hypercholesterolemia.
    Sinitsyn VV; Metlitscaya LM; Mamontova AG; Konovalov GA; Kukharchuk VV
    Biomater Artif Cells Artif Organs; 1990; 18(5):629-35. PubMed ID: 2099218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay.
    Schonfeld G; Pfleger B
    J Clin Invest; 1974 Aug; 54(2):236-46. PubMed ID: 4136225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cholesterol synthesis in the hyperlipoproteinaemias. Polymorphonuclear leucocyte abnormality specific to familial type II hypercholesterolaemia.
    Bremner WF; Third JL; Clark B; Corstorphine C; Lawrie TD
    Atherosclerosis; 1978 Mar; 29(3):291-9. PubMed ID: 208584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-stedy-state studies of low-density-liproprotein turnover in familial hypercholesterolaemia.
    Thompson GR; Spinks T; Ranicar A; Myant NB
    Clin Sci Mol Med; 1977 Apr; 52(4):361-9. PubMed ID: 193666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal enzymatic removal of low density lipoproteins in rabbits: efficacy and safety.
    Shefer SD; Ferreira J; Mullon CJ; Langer R
    Int J Artif Organs; 1993 Apr; 16(4):218-28. PubMed ID: 8325700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.